Ferritin oxidation and proteasomal degradation: Protection by antioxidants

The accumulation of oxidatively damaged proteins is a well-known hallmark of aging and several neurodegenerative diseases including Alzheimer's, Parkinson's and Huntigton's diseases. These highly oxidized protein aggregates are in general not degradable by the main intracellular proteolytic machinery, the proteasomal system. One possible strategy to reduce the accumulation of such oxidized protein aggregates is the prevention of the formation of oxidized protein derivatives or to reduce the protein oxidation to a degree that can be handled by the proteasome. To do so an antioxidative strategy might be successful. Therefore, we undertook the present study to test whether antioxidants are able to prevent the protein oxidation and to influence the proteasomal degradation of moderate oxidized proteins. As a model protein we choose ferritin. H2O2 induced a concentration dependent increase of protein oxidation accompanied by an increased proteolytic susceptibility. This increase of proteolytic susceptibility is limited to moderate hydrogen peroxide concentrations, whereas higher concentrations are accompanied by protein aggregate formation. Protective effects of the vitamin E derivative Trolox, the pyridoindole derivative Stobadine and of the standardized extracts of flavonoids from bark of Pinus Pinaster Pycnogenol® and from leaves of Ginkgo biloba (EGb 761) were studied on moderate damaged ferritin.

[1]  B. Friguet,et al.  Central Role of the Proteasome in Senescence and Survival of Human Fibroblasts , 2003, Journal of Biological Chemistry.

[2]  C. Winterbourn,et al.  Protein carbonyl measurement by a sensitive ELISA method. , 1997, Free radical biology & medicine.

[3]  C. Marsden,et al.  Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease , 1989, Journal of neurochemistry.

[4]  B. Friguet,et al.  Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Formation of cross-linked protein that inhibits the multicatalytic protease. , 1994, The Journal of biological chemistry.

[5]  W. Markesbery,et al.  Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[6]  E. Stadtman,et al.  Recent advances in the analysis of oxidized proteins , 2003, Amino Acids.

[7]  Q. Peng,et al.  Pycnogenol protects vascular endothelial cells from beta-amyloid-induced injury. , 2000, Biological & pharmaceutical bulletin.

[8]  K. Davies,et al.  4-Hydroxynonenal-modified amyloid-β peptide inhibits the proteasome: possible importance in Alzheimer’s disease* , 2000, Cellular and Molecular Life Sciences CMLS.

[9]  J. Cummings,et al.  Huntington's disease. , 1997, The Psychiatric clinics of North America.

[10]  K. Jellinger,et al.  Brain iron and ferritin in Parkinson's and Alzheimer's diseases , 1990, Journal of neural transmission. Parkinson's disease and dementia section.

[11]  Patrizia Mecocci,et al.  Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease , 1994, Annals of neurology.

[12]  H. Sies,et al.  Antioxidant action of stobadine. , 1994, Methods in enzymology.

[13]  A. Bruce-Keller,et al.  Polyglutamine Expansion, Protein Aggregation, Proteasome Activity, and Neural Survival* , 2002, The Journal of Biological Chemistry.

[14]  R. Levine Oxidative modification of glutamine synthetase. I. Inactivation is due to loss of one histidine residue. , 1983, The Journal of biological chemistry.

[15]  H. Griffiths,et al.  The presence of ascorbate induces expression of brain derived neurotrophic factor in SH‐SY5Y neuroblastoma cells after peroxide insult, which is associated with increased survival , 2005, Proteomics.

[16]  B. Friguet,et al.  Age-related impairment of mitochondrial matrix aconitase and ATP-stimulated protease in rat liver and heart. , 2004, European journal of biochemistry.

[17]  K. Davies,et al.  Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during oxidative stress, aging, and disease. , 2004, The international journal of biochemistry & cell biology.

[18]  K. Davies,et al.  Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part II—aging of nondividing cells , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  T. Grune,et al.  Ferritin Oxidation in Vitro: Implication of Iron Release and Degradation by the 20S Proteasome , 2000, IUBMB life.

[20]  J. Sastre,et al.  A Ginkgo biloba extract (EGb 761) prevents mitochondrial aging by protecting against oxidative stress. , 1998, Free radical biology & medicine.

[21]  W. Bors,et al.  Radical Functions in vivo: A Critical Review of Current Concepts and Hypotheses , 1998, Zeitschrift fur Naturforschung. C, Journal of biosciences.

[22]  D. Dearborn,et al.  Protein labeling by reductive methylation with sodium cyanoborohydride: effect of cyanide and metal ions on the reaction. , 1980, Analytical biochemistry.

[23]  R. Dean,et al.  Stable markers of oxidant damage to proteins and their application in the study of human disease. , 1999, Free radical biology & medicine.

[24]  W. Markesbery,et al.  Oxidative Alterations in Alzheimer's Disease , 1999, Brain pathology.

[25]  Aaron Ciechanover,et al.  The Ubiquitin Proteasome System in Neurodegenerative Diseases Sometimes the Chicken, Sometimes the Egg , 2003, Neuron.

[26]  O. Aruoma,et al.  An evaluation of the antioxidant and potential pro-oxidant properties of food additives and of trolox C, vitamin E and probucol. , 1990, Free radical research communications.

[27]  J. Drapier,et al.  Modulation of Iron Regulatory Protein Functions , 1996, The Journal of Biological Chemistry.

[28]  B. Friguet,et al.  Age-dependent protein modifications and declining proteasome activity in the human lens. , 2004, Archives of biochemistry and biophysics.

[29]  E. Stadtman,et al.  Oxidation of methionine residues of proteins: biological consequences. , 2003, Antioxidants & redox signaling.

[30]  E. Stadtman,et al.  Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. , 1993, Annual review of biochemistry.

[31]  C D Marsden,et al.  Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. , 1991, Brain : a journal of neurology.

[32]  M. Hentze,et al.  Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  F. Schmitt,et al.  Evidence of increased oxidative damage in subjects with mild cognitive impairment , 2005, Neurology.

[34]  H. Griffiths,et al.  The effects of vitamin C supplementation on protein oxidation in healthy volunteers. , 2000, Biochemical and biophysical research communications.

[35]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[36]  P. Mecocci,et al.  Plasma Antioxidant Status, Immunoglobulin G Oxidation and Lipid Peroxidation in Demented Patients: Relevance to Alzheimer Disease and Vascular Dementia , 2004, Dementia and Geriatric Cognitive Disorders.

[37]  G. Rimbach,et al.  Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol. , 1999, Free radical biology & medicine.

[38]  K. Davies,et al.  Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  F. V. Defeudis,et al.  Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. , 2000, Current drug targets.

[40]  E. Stadtman,et al.  Conversion of amino acid residues in proteins and amino acid homopolymers to carbonyl derivatives by metal-catalyzed oxidation reactions. , 1989, The Journal of biological chemistry.

[41]  T. Reinheckel,et al.  Degradation of Oxidized Proteins in K562 Human Hematopoietic Cells by Proteasome* , 1996, The Journal of Biological Chemistry.

[42]  T. Reinheckel,et al.  Degradation of oxidized proteins in mammalian cells , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  T. Grune,et al.  Oxidation-induced ferritin turnover in microglial cells: role of proteasome. , 2005, Free radical biology & medicine.

[44]  R. Floyd,et al.  Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. B. Martin,et al.  Molecular basis of the neurodegenerative disorders. , 1999, The New England journal of medicine.

[46]  N. Chondrogianni,et al.  Protein degradation during aging: The lysosome-, the calpain- and the proteasome-dependent cellular proteolytic systems , 2004, Biogerontology.

[47]  E. Stadtman,et al.  Free radical-mediated oxidation of free amino acids and amino acid residues in proteins , 2003, Amino Acids.

[48]  G. Bartosz,et al.  Oxidative modifications of protein structures. , 2000, Advances in clinical chemistry.

[49]  Y. Sagara,et al.  Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. , 2001, Free radical biology & medicine.

[50]  C. Rice-Evans,et al.  Structure-antioxidant activity relationships of flavonoids and phenolic acids. , 1996, Free radical biology & medicine.

[51]  K. Davies,et al.  Dityrosine and tyrosine oxidation products are endogenous markers for the selective proteolysis of oxidatively modified red blood cell hemoglobin by (the 19 S) proteasome. , 1993, The Journal of biological chemistry.

[52]  R. Hough,et al.  Purification of two high molecular weight proteases from rabbit reticulocyte lysate. , 1987, The Journal of biological chemistry.

[53]  Jeffrey N Keller,et al.  The proteasome in brain aging , 2002, Ageing Research Reviews.

[54]  H. Sies,et al.  Antioxidant activity of the pyridoindole stobadine. Pulse radiolytic characterization of one-electron-oxidized stobadine and quenching of singlet molecular oxygen. , 1992, Chemical research in toxicology.

[55]  E. Aylward,et al.  Does CAG repeat number predict the rate of pathological changes in Huntington's disease? , 1998, Annals of neurology.

[56]  L. Packer,et al.  Antioxidant action of Ginkgo biloba extract EGb 761. , 1994, Methods in enzymology.

[57]  K. Davies,et al.  Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part I— effects of proliferative senescence , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[58]  T. Reinheckel,et al.  Proteolysis in Cultured Liver Epithelial Cells during Oxidative Stress , 1995, The Journal of Biological Chemistry.

[59]  B. Friguet,et al.  Inhibition of the multicatalytic proteinase (proteasome) by 4‐hydroxy‐2‐nonenal cross‐linked protein , 1997, FEBS letters.

[60]  M. Ebadi,et al.  Oxidative stress and antioxidant therapy in Parkinson's disease , 1996, Progress in Neurobiology.

[61]  T. Reinheckel,et al.  Degradation of hypochlorite-damaged glucose-6-phosphate dehydrogenase by the 20S proteasome. , 1999, Free radical biology & medicine.

[62]  E. Stadtman,et al.  Glutamic and aminoadipic semialdehydes are the main carbonyl products of metal-catalyzed oxidation of proteins. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[63]  P. Lasch,et al.  Hydrogen Peroxide-induced Structural Alterations of RNase A* , 2001, The Journal of Biological Chemistry.

[64]  Y. Christen,et al.  What is Ginkgo biloba extract EGb 761? An overview--from molecular biology to clinical medicine. , 2002, Cellular and molecular biology.

[65]  L. Beneš,et al.  Pyridoindole stobadine is a potent scavenger of hydroxyl radicals , 1991, FEBS letters.

[66]  Steven Finkbeiner,et al.  Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions , 1998, Cell.

[67]  S. Stolc,et al.  Antioxidant and pharmacodynamic effects of pyridoindole stobadine. , 1998, General pharmacology.

[68]  E. Stadtman,et al.  Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. A possible involvement of intra- and intermolecular cross-linking reaction. , 1993, The Journal of biological chemistry.

[69]  E. Stadtman,et al.  Metal-catalyzed oxidation of proteins. Physiological consequences. , 1991, The Journal of biological chemistry.

[70]  B Daneshvar H Frandsen H Autrupand L O Dragsted γ-Glutamyl semialdehyde and 2-amino-adipic semialdehyde: biomarkers of oxidative damage to proteins. , 1997, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[71]  A. Rego,et al.  Antioxidant effect of flavonoids after ascorbate/Fe(2+)-induced oxidative stress in cultured retinal cells. , 2001, Biochemical pharmacology.

[72]  T. Grune,et al.  Proteasome‐dependent degradation of oxidized proteins in MRC‐5 fibroblasts , 1998, FEBS letters.

[73]  L. Packer,et al.  Antioxidant properties of alpha-tocopherol and alpha-tocotrienol. , 1994, Methods in enzymology.

[74]  T. Reinheckel,et al.  Comparative resistance of the 20S and 26S proteasome to oxidative stress. , 1998, The Biochemical journal.

[75]  R. Nitsch,et al.  Proteasome inhibition by paired helical filament‐tau in brains of patients with Alzheimer's disease , 2003, Journal of neurochemistry.

[76]  J. Gee,et al.  Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain. , 2004, The international journal of biochemistry & cell biology.

[77]  B. Friguet,et al.  Protein maintenance in aging and replicative senescence: a role for the peptide methionine sulfoxide reductases. , 2005, Biochimica et biophysica acta.

[78]  Q. Peng,et al.  Pycnogenol protects vascular endothelial cells from β-amyloid-induced injury. , 2000 .

[79]  S. Aust,et al.  Ferritin and superoxide-dependent lipid peroxidation. , 1985, The Journal of biological chemistry.

[80]  Jeffrey N Keller,et al.  Proteasome Inhibition Alters Neural Mitochondrial Homeostasis and Mitochondria Turnover* , 2004, Journal of Biological Chemistry.

[81]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.

[82]  K. Davies,et al.  Hydrophobicity as the signal for selective degradation of hydroxyl radical-modified hemoglobin by the multicatalytic proteinase complex, proteasome. , 1993, The Journal of biological chemistry.

[83]  C. Ross,et al.  Neurobiology of Huntington's Disease , 1996, Neurobiology of Disease.

[84]  K. Stettmaier,et al.  Arguments against the significance of the Fenton reaction contributing to signal pathways under in vivo conditions , 2000, Free radical research.

[85]  M. Davies,et al.  Markers of protein oxidation: different oxidants give rise to variable yields of bound and released carbonyl products. , 2004, Free radical biology & medicine.

[86]  V. Zelník,et al.  N-oxygenation of stobadine, a gamma-carboline antiarrhythmic and cardioprotective agent: the role of flavin-containing monooxygenase. , 1989, Xenobiotica; the fate of foreign compounds in biological systems.

[87]  R. Levine Carbonyl modified proteins in cellular regulation, aging, and disease. , 2002, Free radical biology & medicine.

[88]  J. Connor,et al.  A Quantitative Analysis of Isoferritins in Select Regions of Aged, Parkinsonian, and Alzheimer's Diseased Brains , 1995, Journal of neurochemistry.

[89]  B. Friguet,et al.  Increase of oxidatively modified protein is associated with a decrease of proteasome activity and content in aging epidermal cells. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.

[90]  K. Davies,et al.  Peroxynitrite Increases the Degradation of Aconitase and Other Cellular Proteins by Proteasome* , 1998, The Journal of Biological Chemistry.

[91]  Carine Nizard,et al.  Algae Extract Protection Effect on Oxidized Protein Level in Human Stratum Corneum , 2004, Annals of the New York Academy of Sciences.

[92]  F. Walker Huntington's disease , 2007, The Lancet.

[93]  P. Harrison,et al.  The ferritins: molecular properties, iron storage function and cellular regulation. , 1996, Biochimica et biophysica acta.

[94]  Q. Peng,et al.  Ginkgo biloba inhibits hydrogen peroxide-induced activation of nuclear factor kappa B in vascular endothelial cells. , 1999, General pharmacology.

[95]  J. Williams,et al.  Determination of carbonyl groups in oxidized proteins. , 2000, Methods in molecular biology.

[96]  T. Grune,et al.  Protein oxidation and proteolysis in RAW264.7 macrophages: effects of PMA activation. , 2001, Biochimica et biophysica acta.

[97]  P. Rohdewald,et al.  A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology. , 2002, International journal of clinical pharmacology and therapeutics.

[98]  K. Davies,et al.  Exposure of hydrophobic moieties promotes the selective degradation of hydrogen peroxide-modified hemoglobin by the multicatalytic proteinase complex, proteasome. , 1994, Archives of biochemistry and biophysics.